Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
about
Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic reviewNon-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base.Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphomaLymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare databaseRole of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomasMucosa-associated lymphoid tissue lymphoma with unusual 18F-FDG hypermetabolism arising at the colorectal anastomosis.Nodal marginal zone lymphoma.Splenic marginal zone lymphoma: disease features and management.Clinical aspects of malt lymphomas.Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1.Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.Survival of patients with gastric lymphoma in Germany and in the United States.Histologic transformation in marginal zone lymphomas†.Splenic Marginal Zone Lymphoma and Concurrent Membranoproliferative Glomerulonephritis With IgMKappa Deposits in a HCV-Seropositive PatientMucosa-associated lymphoid tissue lymphoma arising from the kidney.Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.Significance of imaging and clinical features in the differentiation between primary and secondary pulmonary lymphoma.Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature.Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.Effective management strategies for patients with marginal zone lymphoma.Surgical management of splenic marginal zone lymphoma.Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.A 44-year old male with right-sided facial numbness. Dura-associated extranodal marginal zone B cell lymphoma (MALT lymphoma).Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.Primary pulmonary lymphoproliferative neoplasms.Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.Recent advances in understanding the biology of marginal zone lymphoma.Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma
P2860
Q26996650-B09D379A-D77A-4278-88D1-87D7455511DCQ30975765-43F6773A-F520-4CAF-A9B6-7AA60A16A9F3Q30978936-29A609D7-6880-44C1-83E6-875650C5D8D3Q33587826-9B86EF91-3B43-455B-B35A-96B2E7116957Q35677959-D0BD4131-D7DC-4556-A54D-076F873911C7Q36777008-A7FEFC1F-C6DC-4961-A153-49E60F240159Q37578581-E2F56F30-4CAA-442A-9476-AA0875D7C856Q37624527-946647DA-8B40-4110-B8EE-CA70B07A7E2AQ38134139-35EA98F6-EB26-4406-9DCB-C3FAD001DA00Q38156238-7F811502-4891-4DC2-B482-4318F4ADADF5Q38252813-5BA6AAD2-1B1C-4372-915A-E31E9E36159EQ38686188-5F8192A4-941B-4776-BFE1-EF392606EBA8Q39470633-D6075D3E-843D-4DE9-B2A1-2F5A238FA50CQ40059586-9CFFE4CF-9AEC-41E5-B672-4BA1B793C9E7Q40946968-C269636C-81AB-45F4-8840-047CE0812CE2Q41326723-A70B36C2-E480-4A7C-8B15-D2100BB4F6D4Q41475888-C43D2354-64E6-4D52-BAEA-AD623E6BA30DQ41960827-BB102472-E925-4BA7-8988-BD7285E5ADB8Q44628624-9D0FCF8B-7C8E-40A3-88F2-2198FABB07CBQ45009910-5057680F-EB62-4223-ABB8-C5C4F1109992Q45913843-3C2DD5EF-014B-4F9A-8CED-B53279676D91Q46363527-12FF8EA2-035F-4B66-8621-EEEBC47CF344Q47119181-8B0B214D-5C92-4196-A507-F53E22E9B8CDQ47234653-1138DF54-2F6B-488E-A83E-26E0CBDA769EQ47278073-BEA3745B-9E4D-4ACA-8CD0-3752A7416EA3Q47771527-8390B35B-1C75-43F9-910D-7F916C079A84Q48177913-21BDF089-9D30-4E55-A427-244BF86CCCCDQ48250566-98B3857A-1F0F-4A17-8EA2-A6416A606E87Q48408072-9761730B-81FC-4C51-B846-3D22B40BCF20Q52599792-7B9C292D-382B-441D-A639-228EF7EBDF25Q52716536-40634F4C-E04E-423F-849D-E8103E29B84BQ53039853-899FD492-F578-4C1D-81D7-431A17EEEAF4Q53053965-CB12555C-5386-4D75-81FB-5C18CF69DC01Q53208977-7D3A54E1-F18A-4F1F-9FBE-1F60229EEC28Q55106506-8020CDEF-396E-4377-95A4-A3E0538F87B6Q57759549-D283F5B8-6F9B-44D5-B44A-9CB84D563637
P2860
Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Survival of patients with marg ...... ogy, and End Results database.
@en
Survival of patients with marg ...... ogy, and End Results database.
@nl
type
label
Survival of patients with marg ...... ogy, and End Results database.
@en
Survival of patients with marg ...... ogy, and End Results database.
@nl
prefLabel
Survival of patients with marg ...... ogy, and End Results database.
@en
Survival of patients with marg ...... ogy, and End Results database.
@nl
P2860
P356
P1433
P1476
Survival of patients with marg ...... ogy, and End Results database.
@en
P2860
P304
P356
10.1002/CNCR.27773
P407
P577
2012-08-14T00:00:00Z